OCR 70.23 Omnicare $OCR Hit a 52 week high of 71.51

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
OCR 70.23 Omnicare $OCR Hit a 52 week high of 71.51 Currently at 70.23 +1.50 +2.18% With a day low of 70.08 and a total volume of 318,387.

OCR Omnicare Recent Headline News

Omnicare Announces Conversion Rate Adjustment for Convertible Notes
Thomson Reuters ONE - 1 hr ago
CINCINNATI, November 11, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company" announced today an adjustment to the conversion rate of its 3.75% Convertible Senior Subordinated Notes due 2042 (the "2042 Notes" .
OCR: 69.62 (+0.89)

Omnicare Announces Pricing of Senior Notes Offering
Thomson Reuters ONE - Thu Nov 06, 4:41PM CST
CINCINNATI, November 6, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company" announced today that it has priced its public offering of $400 million aggregate principal amount of 4.75% Senior Notes due 2022 (the "2022 Notes" at 100% of principal amount, and $300 million aggregate principal amount of 5.00% Senior Notes due 2024 (the "2024 Notes" and, together with the 2022 Notes, the "Notes" at 100% of principal amount. The sale of the Notes is expected to close on November 21, 2014, subject to customary closing conditions.
OCR: 69.62 (+0.89)

Omnicare to Present at the Credit Suisse 2014 Health Care Conference
Thomson Reuters ONE - Thu Nov 06, 7:01AM CST
CINCINNATI, November 6, 2014 - Omnicare, Inc. (NYSE:OCR) today announced that it will present at the Credit Suisse Health Care Conference on Tuesday, November 11, 2014 at 3:30 p.m. MST (5:30 p.m. ET) in Phoenix, Arizona.
OCR: 69.62 (+0.89)

Omnicare Set to Possibly Pullback After Yesterday's Rally of 1.67%
Comtex SmarTrend(R) - Wed Nov 05, 5:15PM CST
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $67.53 to a high of $68.55. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $67.31 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OCR: 69.62 (+0.89)

Omnicare Announces Public Offering of Senior Notes
Thomson Reuters ONE - Wed Nov 05, 7:31AM CST
CINCINNATI, November 5, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company" announced today that it plans to offer $700 million aggregate principal amount of senior notes due 2022 and senior notes due 2024 in an underwritten public offering.
OCR: 69.62 (+0.89)

Omnicare Specialty Care Group to Provide Specialty Support Services for New Treatment for IPF - OFEV (nintedanib)
Thomson Reuters ONE - Tue Nov 04, 6:30AM CST
CINCINNATI, November 4, 2014 - RxCrossroads and Advanced Care Scripts (ACS), both divisions of Omnicare Specialty Care Group (SCG), announced today that they have been selected to provide services for patients prescribed Boehringer Ingelheim's OFEV(R) capsules (nintedanib).
OCR: 69.62 (+0.89)

Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
Thomson Reuters ONE - Wed Oct 29, 4:31PM CDT
CINCINNATI, October 29, 2014 - Omnicare, Inc. (NYSE: OCR) announced today that for the period from September 15, 2014 to December 14, 2014 its Series A and Series B Trust Preferred Income Equity Redeemable Securities (NYSE: OCR.PRA and OCR.PRB) (the "Trust PIERS" will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended September 11, 2014, in addition to the continued accrual of regular cash interest.
OCR: 69.62 (+0.89)

Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 69.62 (+0.89), ESRX: 77.69 (-0.30), DVA: 75.04 (+0.32), DGX: 63.14 (+0.45), MD: 62.60 (+0.22)

Omnicare Beats on Q3 Earnings and Sales, Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 11:40AM CDT
Omnicare Inc. (OCR) reported better-than-expected third quarter 2014 results.
PMC: 25.02 (-0.32), OCR: 69.62 (+0.89), CRL: 64.20 (+0.27), ICLR: 53.39 (+0.05)

Look for Shares of Omnicare to Potentially Pullback after Yesterday's 3.70% Rise
Comtex SmarTrend(R) - Fri Oct 24, 5:17PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $64.31 to a high of $67.66. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $65.24 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OCR: 69.62 (+0.89)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 4:37PM CDT

OCR: 69.62 (+0.89), HTCH: 3.70 (unch), CIG: 5.72 (+0.08), FBR: 12.21 (+0.16), VSR: 3.05 (+0.02), LAKE: 12.90 (-0.08), NGD: 3.86 (+0.25), RGLS: 20.20 (-0.71), PX: 126.70 (+0.33), MLNX: 44.15 (-0.29)

Omnicare's (OCR) CEO Nitin Sahney on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:22PM CDT

OCR: 69.62 (+0.89)

Omnicare (OCR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Oct 24, 7:55AM CDT

OCR: 69.62 (+0.89)

Omnicare beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 7:15AM CDT

OCR: 69.62 (+0.89)

Omnicare tops 3Q profit forecasts
Automated Insights - Fri Oct 24, 6:48AM CDT
CINCINNATI (AP) _ Omnicare Inc. (OCR) on Friday reported third-quarter net income of $64.8 million.
OCR: 69.62 (+0.89)

Omnicare Reports Third-Quarter 2014 Financial Results; Company Updates Full-Year 2014 Guidance
Thomson Reuters ONE - Fri Oct 24, 6:16AM CDT
CINCINNATI, October 24, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2014.
OCR: 69.62 (+0.89)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT

WYN: 79.14 (+1.47), SFE: 19.80 (-0.30), F: 14.20 (+0.20), OCR: 69.62 (+0.89), B: 36.49 (-0.13), SXC: 23.00 (-0.37), VTR: 68.50 (-0.11), UPS: 108.44 (-0.61), DLPH: 70.30 (+0.43), CHH: 53.71 (+1.04), LYB: 87.93 (-0.10), COG: 33.60 (+0.40), SHPG: 202.09 (+1.11), TCB: 15.70 (-0.08), AVY: 47.99 (-0.05), AAN: 26.73 (+0.67), MGLN: 61.37 (+0.89), STT: 77.73 (-0.39), FNFG: 7.45 (unch), IMGN: 9.89 (-0.06), EDU: 21.90 (+0.24), BMY: 58.69 (-0.12), DTE: 82.56 (-1.29), LEA: 92.49 (-0.81), MCO: 99.39 (+0.07), FLIR: 33.02 (-0.19), IMS: 24.32 (-0.10), LPNT: 66.06 (+0.26), ERIC: 11.92 (+0.30), PG: 89.64 (+0.19), IDXX: 151.93 (+4.75), WBC: 101.63 (-0.40), NDAQ: 44.23 (+0.20), CL: 68.45 (-0.10)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.98 (-0.11), TTC: 62.78 (-0.17), HST: 22.75 (-0.01), OCR: 69.62 (+0.89), HI: 34.44 (+0.02), MAIN: 32.22 (-0.03), MHLD: 12.66 (+0.21), PRU: 86.21 (-0.33), DEI: 27.77 (-0.76), PSA: 187.49 (-0.63), THG: 69.14 (-0.09), KKR: 21.68 (-0.16), RL: 171.24 (-0.68), VTR: 68.50 (-0.11), AEP: 57.68 (-0.70), EVR: 50.95 (-0.73), TECH: 91.58 (+0.48), ROK: 112.31 (-0.44), INGR: 79.99 (-0.57), WTI: 9.39 (+0.49), COR: 37.79 (-0.06), EXL: 12.90 (-0.12), UG: 19.13 (+0.13), BGS: 28.74 (-0.86), ESV: 39.35 (-0.57), APTS: 8.71 (-0.03), EL: 72.80 (-0.03), HEI: 53.04 (-1.38), GE: 26.32 (-0.15), BOKF: 68.19 (-0.45), SNA: 135.20 (-0.56), BCPC: 68.17 (+2.44), SBUX: 77.83 (+0.18), V: 249.15 (-1.06), KIM: 24.77 (-0.17), BBSI: 22.48 (-1.80), SIX: 40.13 (+0.20), EMCI: 33.20 (+0.05), CHS: 15.11 (+0.05), NEU: 389.36 (-0.61), BMR: 21.54 (-0.11), EMN: 84.05 (+0.21), PRA: 44.99 (-0.15), CBL: 18.97 (-0.43), CUBE: 20.94 (-0.16), DIS: 89.65 (-0.13), BMY: 58.69 (-0.12), ABC: 87.85 (+0.14), RCII: 31.96 (+0.29), WCN: 50.37 (+0.03), HCI: 43.92 (+0.01), MAC: 69.13 (-0.42), AMTD: 35.35 (+0.29), HUB.B: 112.16 (+0.36), JCI: 49.44 (+0.27)

Omnicare Larger Than S&P 500 Component News Corp NWSA
TheOnlineInvestor.com - Tue Oct 07, 3:51PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Omnicare Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example News Corp , according to The Online...
OCR: 69.62 (+0.89)

'Mad Money' Lightning Round: Buy, Buy, Buy Kohlberg Kravis Roberts
at The Street - Sat Oct 04, 5:00AM CDT
Cramer likes McKesson and Corning but isn't recommending Sanchez Energy.
KNDI: 15.76 (+0.90), VIPS: 24.29 (-0.22), OCR: 69.62 (+0.89), MCK: 202.00 (+0.72), SN: 16.99 (+0.35), KKR: 21.68 (-0.16), GLW: 20.76 (-0.04), AAPL: 108.89 (+0.06), FI: 19.43 (+0.35), BABA: 115.22 (-3.93)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Cisco's Chief Discusses Entry-Level Hiring Trends and AI

Updated Category News Views 192

Cisco's Insights on Entry-Level Hiring Trends The landscape of entry-level job opportunities is seeing a notable shift. Data from an industry student platform reveals a decrease in job postings for recent graduates. The statistics indicate a 16% year-over-year drop in entry-level positions, sparking concern among graduates and job seekers. Understanding the Current Job...

Continue Reading
FMC’s Rimisoxafen: The Game-Changer Amid Weeds' Rebellion

Updated Category News Views 248

FMC's Bold Move in the Herbicide Game Honestly, this takes me back to the dot-com era—not in tech, but in agriculture. FMC Corporation (NYSE:FMC) just pulled a doozy by getting rimisoxafen classified as a dual mode of action herbicide. This baby’s not just a gimmick; it’s a big deal for a sector that's wrestling down weeds like Palmer amaranth that’ve become a...

Continue Reading
Chord Energy Announces Earnings Call for Q2 2025 Results

Updated Category News Views 168

Chord Energy Earnings Release and Conference Call Details Chord Energy Corp. (NASDAQ: CHRD) has exciting news as it gears up to announce its financial and operational results for the second quarter of 2025. This announcement is scheduled to occur after the market closes, on an appointed date that follows the pattern of previous releases. Live Webcast and Conference Call...

Continue Reading
TuniTuni Thrives Globally with Unique Storytelling Approach

Updated Category News Views 338

TuniTuni: A Global Pioneer in Toddler Development TuniTuni is redefining early childhood physical education through its innovative approach that combines storytelling with the essential elements of physical movement. Since its inception in 2003, this leading brand has garnered attention in various regions, particularly emphasizing the importance of physical activity for...

Continue Reading
Investigation into Open Lending Holdings for Investor Losses

Updated Category News Views 363

Investigation into Open Lending Holdings for Investor Losses Faruqi & Faruqi, LLP is taking steps to look into potential claims on behalf of investors who have faced considerable losses related to Open Lending Corporation (NASDAQ: LPRO). If you have experienced financial setbacks from your investments in Open Lending, it’s important to know that you're not alone and...

Continue Reading